Article citationsMore>>
Zhang, Y., Ding, J., Ren, S., Wang, W., Yang, Y., Li, S., et al. (2020) Intravenous Infusion of Human Umbilical Cord Wharton’s Jelly-Derived Mesenchymal Stem Cells as a Potential Treatment for Patients with COVID-19 Pneumonia. Stem Cell Research & Therapy, 11, Article No. 207.
https://doi.org/10.1186/s13287-020-01725-4
has been cited by the following article:
-
TITLE:
Mesenchymal Stem Cells: Potential Role against Bacterial Infection
AUTHORS:
Basem Battah
KEYWORDS:
Mesenchymal Stem Cells, Bacterial Infection, Antibiotic Resistance
JOURNAL NAME:
Journal of Biosciences and Medicines,
Vol.10 No.3,
March
14,
2022
ABSTRACT: The worldwide spread of bacterial resistance makes finding new therapeutics to overcome this ongoing problem an urgent need. Mesenchymal stem cells (MSCs) exert potential inhibiting activity against bacterial infections. The antimicrobial activity of MSCs relies on direct and indirect effects by secreting paracrine factors with potential inhibiting activity against bacterial growth or stimulating the phagocytic activity of the immune cells. These effects appeared when MSCs or its secreted factors are administrated therapeutically. Therefore, MSCs based cell therapy could be considered as a novel promising strategy to enhance the antibiotic activity in multidrug resistant (MDR) infections.
Related Articles:
-
Nike Hendrijantini, Utari Kresnoadi, Sherman Salim, Bambang Agustono, Endang Retnowati, Iwan Syahrial, Pungky Mulawardhana, Manggala Pasca Wardhana, Coen Pramono, Fedik Abdul Rantam
-
Ermei Luo, Jiawen Zhang, Jing Liu, Li Yu, Mingqiao Tang
-
Mobina Vatankhah
-
Mahmoud Hashemitabar, Elham Allahbakhshi, Mohamad Reza Tabande, Mahmoud Orazizadeh, Fereshteh Nejad Dehbashi, Saeed Azandeh, Kambiz Ahmadi Engali, Darioush Bijan Nejad
-
Neslihan Sinim Kahraman, Ayse Oner